Can-Fite BioPharma Ltd. (CANF) stock
CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.49−0.06 (-3.87%)
Close on Nov 12, 2026Market cap $1.95MP/E –Yield –
Can-Fite BioPharma EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was -$5.97. The highest annual figure on record is $900.00 in fiscal 2016.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.97 | – |
| FY2024 | Dec 31, 2024 | -$10.86 | – |
| FY2023 | Dec 31, 2023 | -$17.92 | – |
| FY2022 | Dec 31, 2022 | -$30.00 | – |
| FY2021 | Dec 31, 2021 | -$90.00 | – |
| FY2020 | Dec 31, 2020 | -$120.00 | – |
| FY2019 | Dec 31, 2019 | -$420.00 | – |
| FY2018 | Dec 31, 2018 | -$510.00 | – |
| FY2017 | Dec 31, 2017 | -$420.00 | -146.7% |
| FY2016 | Dec 31, 2016 | $900.00 | +11.1% |
| FY2015 | Dec 31, 2015 | $810.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?